Seragem has demonstrated the blood circulation improvement effects of its medical device, the Celtron Circulation Chair.
According to Seragem, a clinical study showed that after a single 30-minute use of the Celtron Circulation Chair, blood flow in the back of the hand increased by 8.01% compared to before use, confirming its effectiveness in enhancing blood circulation.
The Celtron Circulation Chair is a chair-type medical device that applies Seragem's advanced technology. It has been certified by the Ministry of Food and Drug Safety for two benefits: improving blood circulation and alleviating muscle pain. It is designed for comfortable use while seated, helping users manage blood circulation and relieve muscle pain in their daily lives.
This study was conducted by Seragem Clinical, the company's clinical research organization, involving 40 participants aged 19 to 65. After using the circulation mode of the Celtron Circulation Chair for 30 minutes, the blood flow in the back of the hand was compared before and after use, showing a statistically significant improvement of 8.01% in the primary evaluation indicator.
Meanwhile, the Celtron Circulation Chair was launched in May of last year, and sales from January to April of this year have increased by approximately 60% compared to the previous four months, indicating a strong upward trend.
A Seragem representative stated, "We will continue to build trust by verifying the effectiveness and safety of our products based on 28 years of expertise in medical device technology and research and development capabilities."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.